Objective: To investigate whether intravitreally applied haemangioblasts (HB) derived from human embryonic stem cells (hESCs) are helpful for the repair of vascular damage caused in animals by an oxygen-induced retinopathy (OIR), by an induced diabetic retinopathy (DR) or by an induced retinal ischaemia with subsequent reperfusion. Methods: Human embryonic stem cell-derived HBs were transplanted intravitreally into C57BL/6J mice (OIR model), into male Wistar rats with an induced DR and into male Wistar rats undergoing induced retinal ischaemia with subsequent reperfusion. Control groups of animals received an intravitreal injection of endothelial cells (ECs) or phosphate-buffered saline (PBS). We examined the vasculature integrity in the mice with OIR, the blood-retina barrier in the rats with induced DR, and retinal thickness and retinal ganglion cell density in retina flat mounts of the rats with the retinal ischaemic-reperfusion retinopathy. Results: In the OIR model, the study group versus control groups showed a significantly (p < 0.001) smaller retinal avascular area [5.1 AE 2.7%;n = 18 animals versus 12.2 AE 2.8% (PBS group; n = 10 animals) and versus 11.8 AE 3.7% (EC group; n = 8 animals)] and less retinal neovascularization [6.3 AE 2.5%;n = 18 versus 15.2 AE 6.3% (n = 10; PBS group) and versus 15.8 AE 3.3% (n = 8; EC group)]. On retinal flat mounts, hESC-HBs were integrated into damaged retinal vessels and stained positive for PECAM (CD31) as EC marker. In the DR model, the study group versus the EC control group showed a significantly (p = 0.001) better blood-retina barrier function as measured at 2 days after the intravitreal injections [study group: 20.2 AE 12.8 ll/(g 3 hr); n = 6; versus EC control group: 52.9 AE 9.9 ll/(g 3 hr; n = 6)]. In the retinal ischaemia-reperfusion model, the groups did not differ significantly in retinal thickness and retinal ganglion cell density at 2, 5 and 7 days after baseline. Conclusion: By integrating into damaged retinal vessels and differentiating into ECs, intravitreally administered hESC-HBs may have partially repaired a retinal vascular injury caused by OIR model and DR.
Introduction
Retinal vascular diseases such as DR and retinal vein occlusions belong to the most common causes for loss of vision worldwide (Bourne et al. 2013; Stevens et al. 2013) . Recent developments in medical treatment of these retinal vascular disorders showed a marked therapeutic progress by increasing vision in clinical situations in which up to that time stabilization at best could be expected. These new medical developments included the intravitreal application of slow release steroids for treatment of macular oedema, and the intraocular injection of vascular endothelial growth factor (VEGF) antibodies to regress and prevent unwanted intraocular neovascularization (Jonas 2005; Avery et al. 2006; Rosenfeld et al. 2006) . The increase in vision by these medical developments was markedly limited by the amount of preceding loss of retinal tissue due to the degree of capillary malperfusion . Consequently, the next qualitative step in the therapy of retinal vascular diseases would be the development of strategies to improve capillary malperfusion and prevent the secondary loss of retinal cells. Newly emerging paradigms have described the existence of a trophic crosstalk between local vascular networks and the tissues supplied by them in a variety of organ systems (Matsumoto et al. 2001; LeCouter et al. 2003; Otani et al. 2004 ). In addition, vascular ECs have been reported to provide trophic substances which stimulate self-renewal and expand differentiation of neural stem cells in their vicinity (Shen et al. 2004; Friedlander et al. 2007 ). In view of such an interdependency of vascular ECs and the surrounding tissues, the question arose whether one could use vascular cells or its precursors to rescue the dependent surrounding cells in the face of severe stress such as hypoxia (Friedlander et al. 2007) . A new paradigm was proposed to 'mature' otherwise immature vasculature or, yet better, to make existing vasculature more resistant to hypoxic damage by the use of haematopoietic stem cells. These haematopoietic stem cells were derived from autologous bone marrow or cord blood or other sources. Friedlander and colleagues demonstrated that bone marrow contained a population of endothelial and myeloid progenitor cells that could target activated astrocytes, a hallmark of many retinal diseases, and participate in normal developmental, or injury-induced, angiogenesis in the adult. Friedlander and his team reported that an intravitreal injection of these bone marrowderived cells from mice and humans prevented retinal vascular degeneration normally observed in mouse models of retinal degeneration. They concluded that stem cell grafts for the treatment of retinal vascular and degenerative diseases represented a novel concept to stabilize existing vasculature to hypoxic damage and/or rescue and protect retinal neurons. Besides obtaining vascular progenitor cells or stem cells from the bone marrow as described by Friedlander and associates, Lu and co-workers described a method for generating large numbers of these bipotential progenitors -known as HBs -from hESCs using an in vitro differentiation system (Lu et al. 2007 (Lu et al. , 2009 (Lu et al. 2009; Kimbrel et al. 2014) . The ECs derived from hESC-HBs expressed typical EC markers and uptake of Dil-Ac-LDL, and formed vascular networks on Matrigel (Lu et al. 2007) . Similarly, vascular smooth muscle cells derived from hESC-HBs contracted in response to stimulation by carbachol and formed vasculature-like networks in alignment with ECs on Matrigel (Lu et al. 2009 ). When hESC-HBs were injected into mice with ischaemic injury of the retina, they showed a robust reparative function of the damaged vasculature (Lu et al. 2007) .
In view of the need of a new therapeutic modality in treatment of patients with retinal vascular diseases and in view of the potentials the new developments in cell biology offer, we conducted this study to examine whether hESC-HBs implanted into the vitreous cavity alleviated the consequences of retinal vascular diseases in animals with an OIR model, an experimental DR model and a retina ischaemic reperfusion model.
Materials and Methods
The hESC H1-green fluorescent protein (GFP) line [National Institute of Health (NIH) designated as WA01) was used for the generation of HBs as reported previously (Lu et al. 2007 (Lu et al. , 2008 . Cells were cultured on mitomycin C-treated feeder mouse embryonic fibroblasts (MEFs) in hESC medium supplemented with 20% KnockOut Serum Replacement (Invitrogen, Carlsbad, CA, USA http://www.invitrogen.com), 10 ng/ml basic fibroblast growth factor (bFGF; Stemgent, Cambridge, MA, USA, www.stemgent.com), b-mercaptoethanol (Sigma-Aldrich, St. Louis, MO, USA, http://www.sigmaaldrich.c om), non-essential amino acids (NEAA), and GlutaMAX-I and penicillin/streptomycin (Invitrogen). The cells were fed with fresh medium daily, and confluent hESC cultures were split using 1 mg/ml collagenase IV in Dulbecco's modified Eagle's medium/F12 (Invitrogen).
We incubated hESC cultures with collagenase IV at 37°C for up to 10 min and collected the large clumps of cells. The clumps were washed once with 5 ml hESC medium. To initiate differentiation, the cell clumps were resuspended in embryoid body (EB) differentiation medium [Stemline II supplemented with 50 ng/ml BMP4 (R&D Systems Inc., Minneapolis, MN, USA, http://www.rndsystems.c om) and VEGFL (Invitrogen)], at a density of approximately 2 9 10 6 cells per well of a six-well ultralow attachment plate (Corning Life Sciences, Lowell, MA, USA, http://www.corn ing.com/lifesciences). Haemangioblasts (HB) were generated as previously described (Lu et al. 2007 (Lu et al. , 2008 . Briefly, EBs were cultured in differentiation medium for 48 hr, and then, half of the medium was replaced with medium containing BMP4 (50 ng/ml), VEGF (50 ng/ml) and bFGF (20 ng/ ml). After 24-hr incubation, the EBs were collected, washed once in 2 ml DPBS (Invitrogen) and incubated with 1 ml of trypsin/EDTA (Invitrogen) at 37°C for 2-3 min. The EBs were dissociated by pipetting up and down 10 times using a 1000 ll pipette or until the cell suspension became homogenous with no visible clumps. An equal volume of MEF medium was added, and the cells were centrifuged at 210 g for 4 min. The cell pellet was resuspended in Stemline II medium to 1-2 9 10 6 cells/ml; 5 9 10 4 cells were plated in 1-2 ml of blast growth medium (BGM) and then incubated for up to 6 days. Haemangioblasts (HB) were collected 6-7 days after replating and frozen in liquid nitrogen.
As animals, we used C57BL/6J mice and male Wistar rats (Vital River Animal Laboratories, Beijing, China The OIR was induced in C57BL/6J mice according to the protocol described by Smith et al. (1994) . Briefly, 7-day-old mice (P7) were incubated in 75% oxygen for 5 days and then returned to normal air. The hyperoxic environment was created and maintained using a chamber. The DR model was induced in male Wistar rats weighing approximately 200 g and which received a single 60 mg/kg intraperitoneal injection of Streptozotocin (Sigma) in 10 mmol/l citrate buffer (pH 4.5) after overnight fast (Ishida et al. 2003) . Animals with blood glucose levels >250 mg/dl after 24 hr were considered diabetic. These animals were allowed free access to standard laboratory chow and water in an air-conditioned room.
The retinal ischaemia and reperfusion model was applied in male Wistar rats weighing approximately 200 g. After anesthetizing the animals, the anterior chamber of one eye was cannulated with a 26-gauge needle connected to a reservoir containing 0.9% NaCl (Zheng et al. 2007 ). The intraocular pressure was raised by elevating the reservoir. Retinal ischaemia was confirmed by direct observation of the total occlusion of retinal vessels and subsequent whitening of the retina. The whitening of the iris and total occlusion of iris vessels were additional indirect signs. The duration of ischaemia was 60 min for rats. At the end of the procedure, the needle was gently withdrawn from the anterior chamber, the intraocular pressure was normalized, and retinal reperfusion was confirmed upon ophthalmoscopy.
For intravitreal transplantation of the HBs in the OIR model, 1 9 10 4 GFP-HBs in 1 ll PBS were injected intravitreally at the 12th postnatal day (P12) when the mice were relocated from cages with 75% oxygen into cages with room atmosphere. In the DR model, 5 9 10 4 GFP-HBs suspended in 5 ll PBS were injected into the vitreous cavity at 6 weeks after the successful induction of diabetes. In the IR model, 5 9 10 4 GFP-HBs in 5 ll PBS were injected intravitreally immediately after normalization of intraocular pressure. The eyes in the control group received the same volume of PBS intravitreally.
To assess cell migration and cell differentiation, HBs derived from H1-GFP hES cells were used for transplantation, so that their migration could be traced by fluorescent microscope. CD31, an EC marker (Pharmingen; BD Bioscience, San Jose, CA, USA), was used to assess whether the injected HBs differentiated into endothelium. Some eyes were fixed in 4% PFA for 1 hr, and the retinas were then dissected and were flat-mounted. Other eyes were fixed in 4% PFA for 24 hr and then immersed in 30% sucrose for another 24 hr. Other eye globes were embedded in optimal cutting temperature (OCT) embedding medium, and frozen sections were prepared. The flat-mounted retinas and the sections were immersed in 3% H 2 O 2 for 20 min and then washed three times by PBS. They were then treated in 1% triton 15 min and washed thrice in PBS followed by blocking in 10% NGS for 1 hr at room temperature. It was followed by overnight incubation with CD31 antibody.
The quantification of vascular obliteration and preretinal neovascular tufts was performed at the 17th postnatal day (P17). Briefly, the globes were fixed in 4% PFA for 20 min, and the retinas were dissected and fixed in methanol for 15 min on ice and washed three times by PBS followed by blocking in 20% FBS/20% NGS for 1 hr at room temperature. It was followed by an overnight incubation with GS lectin conjugated to a fluorescent label to identify vessels (Invitrogen). The retinas were flat-mounted with radialrelaxing incisions to obtain wholemount preparations. Images of the retinal vasculature were obtained using a fluorescent microscope (BX51; OLYMPUS, Tokyo, Japan). Quantification of vaso-obliteration and neovascularization was carried out as described previously . In brief, the area of vascular obliteration was measured by delineating the avascular zones in the central retina of GS lectin-stained retinas and calculating the total area using Photoshop CS2 (Adobe, San Jose, CA, USA) software (version 3.0; Improvisation). Similarly, the area of preretinal neovascularization (tufts) was calculated using fluorescent images. Student's ttest was applied to statistically compare the different experimental groups.
For analysis of the blood and retina barrier breakdown in DR model, the rats received in deep anaesthesia an intravenous injection of FITC-conjugated dextran (4.4 kDa, 50 mg/ml in PBS, 50 mg/kg BW; Sigma). After 10 min, the thorax was opened and a 15-gauge perfusion cannula was introduced into the aorta. A blood sample was collected immediately before perfusion. After drainage was achieved from the right atrium, each rat was perfused with PBS (500 ml/kg BW) to clear the remaining intravascular dextran. The blood sample was centrifuged at 5862 g for 20 min at 4°C, and the supernatant was diluted at 1:1000. Immediately after perfusion, the retinas were carefully removed, weighed and homogenized to extract the FITC-dextran in 0.4 ml of water. The extract was processed through a 30 000-molecular-weight filter (Ultrafree-MC; Millipore, Bedford, MA, USA) at 5862 g for 90 min at 4°C. The fluorescence in each 200 ll sample was measured (excitation, 485 nm; emission, 538 nm), using a spectrofluorometer (LS55; PerkinElmer, Waltham, MA, USA) with water as a blank. Corrections were made by subtracting the autofluorescence of retinal tissue from rats without FITC-dextran injection. The amount of FITC-dextran in each retina was calculated from a standard curve of FITC-dextran. For normalization, the retinal FITC-dextran amount was divided by the retinal weight and by the concentration of FITC-dextran in the plasma. The blood-retina barrier breakdown was calculated using the following equation: [Retinal FITC-dextran (g)/retinal weight (g)]/[Plasma FITC-dextran concentration (g/l) 9 circulation time (hr)], with the results being expressed in microlitres per gram per hour.
Retinal thickness and the density of the retinal ganglion cells were measured in ischaemia-reperfusion model. The enucleated eyes were fixed in 10% buffered formalin and embedded in paraffin. Ten-micrometer-thick sagittal sections were stained with haematoxylin and eosin and examined upon light microscopy. The thickness of the retinal layers was measured at a distance of 1.5 mm to the centre of the optic nerve head (Zheng et al. 2007) .
Four days after the ischaemia-reperfusion experiment, the retinal ganglion cells were retrogradely labelled by injection of 4 ll fluorescent tracer (FluoroGold; Biotium, Freemont, CA, USA) into both superior colliculi using a stereotactic device (Jehle et al. 2008) . The rats were sacrificed 3 days after labelling; the eyes were removed and fixed for 30 min in paraformaldehyde. The retinas were dissected, flatmounted on gelatin-coated glass slides and embedded in mounting media. Tracer-positive retinal ganglion cells were counted in a masked fashion under a fluorescence microscope (BX51; OLYMPUS) in four distinct areas measuring 0.091 mm 2 each.
Results

Oxygen-induced retinopathy (OIR) model
Five days after exposure to an atmosphere of 75% oxygen, C57BL/6L mice at an age of 12 postnatal days without any further invention showed large areas of retina in which the retinal vasculature was partially occluded without that neovascularization and disorganized vasculature were observed (Fig. 1A,B) . Five days after these mice had been relocated into normal room atmosphere, retinal neovascularization and disorganized retinal blood vessels were detected in the areas with damaged retinal vasculature (Fig. 1C) . Mice which underwent the same regimen for the development of an OIR and which received an intravitreal injection of hESC-HBs, ECs or PBS were examined at an age of 17 postnatal days. Animals receiving the intravitreal injection of PBS showed large areas of central retina without vasculature ( Fig. 2A,D) . Similar findings were observed in animals receiving an intravitreal application of ECs (Fig. 2B,E) . The size of the regions of avascular retina did not differ between both groups [PBS group: 12.2 AE 2.8% (n = 10 animals); EC group: 11.8 AE 3.7% (n = 8 animals); Fig. 3] . In both groups, the size of the region with avascular retina was significantly The size of retinal regions with abnormal or newly formed retinal vessels measured in the group of mice with an intravitreal injection of PBS [15.2 AE 6.3% (n = 10 animals)] and measured in the group of mice with an intravitreal injection of ECs [15.8 AE 3.3% (n = 8 animals); Fig. 3C ] did not differ significantly between both groups, while the region was significantly (p < 0.001) smaller in the group of mice with an intravitreal injection of hESC-HBs [6.3 AE 2.5% (n = 18 animals); Fig. 3C ].
Flat mounts of the retina showed that hESC-HBs were detected to be integrated into damaged vasculatures (Fig. 4A ,B,C), with these cells staining positive for PECAM [CD31; Fig. 5A -C], a marker for ECs.
Diabetic retinopathy (DR) model
As examined at 2 weeks after the onset of induced diabetes mellitus, the rats with induced diabetes mellitus and rats of the control group without diabetes mellitus did not differ significantly (p = 0.94) in the blood-retina barrier function as assessed by FITC-conjugated dextran [diabetic group: 9.8 AE 8.6 ll/(g 9 hr) (n = 10 animals); diabetic group: 10.1 AE 6.9 ll/(g 9 hr)] (n = 12 animals). At 6 weeks after onset of induced diabetes mellitus, the blood-retina barrier function had significantly (p = 0.005) deteriorated in the diabetic group [32.9 AE 23.1 ll/(g 9 hr)
(n = 10 animals; Fig. 6A ].
Rats which received an intravitreal injection of hESC-HBs as compared to rats with an intravital injection of PBS at 6 weeks after onset of diabetes showed a significantly (p = 0.001) better blood-retina barrier function as measured at 2 days after the intravitreal injections [hESC-HBs group: 20.2 AE 12.8 ll/(g 9 hr) (n = 6 animals) versus PBS group: 52.9 AE 9.9 ll/(g 9 hr) (n = 6 animals); Fig.  6B ]. Measured at 4 days and 10 days after the intravitreal injection, the blood-retina barrier function was still higher in the hESC-HBs than in the PBS group; the difference, however, was not statistically significant (Fig. 6B) . Further analysis showed hESC-HBs homed to and integrated into the injured vasculature with characteristics of ECs (Fig. 7) .
The group of rats with intravitreally administered hESC-HBs as compared to the group of rats with intravitreal PBS injection did not differ significantly in retinal thickness and retinal ganglion cell density as measured at 2, 5 and 7 days after the intravitreal applications (Fig. 8) .
Ischaemia/reperfusion model
The group of rats with intravitreally administered hESC-HBs as compared to the group of rats with intravitreal Fig. 3 . Percentage of retinal area without detected vascularization on the total retinal area (A,B) and percentage of the regions with abnormal or newly formed retinal vessels on the total retinal area (C) in C57BL/6L mice which developed an oxygen-induced retinopathy (OIR) model and which received an intravital injection of phosphate-buffered saline (group PBS), endothelial cells (group EC) or human embryonic stem cell (hESC)-derived haemangioblasts (group HB). (A and C) shows the measurements taken at an age of 17 postnatal days, 5 days after the animals had returned from the oxygen-enriched atmosphere to a normal room atmosphere. (B) shows the findings obtained at the 12th postnatal day just after finishing a 5-days period in a 75% oxygen atmosphere and before hESCs-derived haemangioblasts (group HB) or endothelial cells (group EC) were intravitreally injected into other animals of the same groups.
(A) (B) (C) Fig. 4 . Integration of human embryonic stem cell-derived haemangioblasts (HB) into retinal vasculature; (A) retinal vasculature visualized by isolectin; (B) the same section was photographed using green fluorescent protein (GFP) filter; (C) merged image of (A) and (B).
PBS injection did not differ significantly in retinal thickness and retinal ganglion cell density as measured at 2, 5 and 7 days after the intravitreal applications (Figs 9,10 ).
Discussion
Our experimental study suggests that in the OIR model, the intravitreal application of hESC-HBs as compared to the intravitreal administration of ECs or of PBS resulted in a reduction in the size of the retinal region without detected vascularity and a decrease in the amount of retinal neovascularization. It also appeared that the hESCHBs were integrated into damaged retinal vessels (Fig. 4A ,B,C) and that these cells showed characteristics of ECs. One may conclude that the hESCHBs, by integrating into the damaged retinal vessels and differentiating into ECs, partially repaired the vascular injury caused by the OIR model and inhibited the neovascularization by reducing the vascular obliteration. Interestingly, intravitreal application of ECs did not show a similar effect. As a corollary, rats with induced DR and receiving an intravitreal application of hESC-HBs as compared to rats with an intravital injection of PBS showed a significantly (p = 0.001) better blood-retina barrier function. Again it appeared that the hESC-HBs integrated into the retinal vasculature with characteristics of ECs (Fig. 7) . The findings obtained in our study agree with the observations made in previous investigations. Ritter and colleagues reported that Lin -haematopoietic stem cells were able to repair vascular injury after intravitreal application and that the . Blood-retinal barrier function as examined by FITC-conjugated dextran in normal rats of a control group ('normal'), rats with induced diabetes mellitus at 2 weeks after onset of diabetes ('DM 2w') and at 6 weeks after onset of diabetes ('DM 6w'; A); (B) rats with induced diabetes mellitus at 6 weeks after onset of diabetes and which received an intravitreal injection of human embryonic stem cell-derived haemangioblasts ('HB') or of phosphate-buffered saline ('PBS'), as examined at 2, 4, and 10 days after the intravitreal application.
repairing capacity was related to the expression of the HIF-1a factor ). Lu and associates reported that hESC-HBs when injected into rats with spontaneous type II diabetes homed to the site of vascular injury and showed a reparative function of the damaged vessels (Lu et al. 2007 ). As in our study, fluorescent immunocytochemistry and confocal microscopy revealed that the vascular lumina of the rats were surrounded by human ECs and smooth muscle cells. Interestingly, the intravitreal application of hESC-HBs was not associated with a short-term neuroprotective effect as there was no significant difference in retinal thickness and retinal ganglion cell density between animals with intravitreally applied hESC-HBs and animals with intravitreal injection of PBS in the retinal ischaemia-reperfusion model. The reason may have been an important limitation in our study design, in that the follow-up was too short with 10 days or less. In particular, in the retinal ischaemiareperfusion model, a longer follow-up might have been necessary to detect, or to exclude, significant differences in retinal ganglion cell density and retinal thickness. Also, a TUNEL staining might have been necessary to detect differences in the number of apoptotic 8 . Density of retinal ganglion cells in rats with induced diabetes mellitus at 6 weeks after onset of diabetes and additional 4 days after an intravitreal injection of human embryonic stem cell-derived haemangioblasts ('HB') or of phosphate-buffered saline ('PBS'), with no significant difference between both groups. retinal ganglion cells between the groups. The mechanism underlying the potentially reparative function of hES-HBs has remained unclear so far. As the formation of functional vessels needs both ECs and smooth muscle cells, one may discuss that a damage to the retinal vasculature as it occurs in the OIR involves both, ECs and pericytes, so that the repair has to address both cell systems. It may explain that hESC-HBs in contrast to ECs were able to reduce the retinal region with avascularity as hES-HBs could develop into both, ECs and smooth muscle cells and pericytes. Another possibility may be that the hESC-HBs secreted factors which were involved in the repair of damaged retinal vasculature, while the adult ECs no longer had the ability to secret such factors.
The currently only one available medical treatment option for the macular oedema and retinal neovascularization due to retinal ischaemia is the intravitreal application of anti-VEGF drugs and triamcinolone acetonide (Jonas 2005; Avery et al. 2006; Rosenfeld et al. 2006) . Studies have not shown an improvement nor a deterioration in retinal perfusion in association with this intraocular medical therapy (Michaelides et al. 2010) . Future studies may address whether the intravitreal application of autologous bone marrow-derived mononuclear cells including HBs could be of help in treating ischaemic retinal diseases and opening up a new therapeutic avenue (Jonas et al. 2008 (Jonas et al. , 2010 .
Limitations of our study should be discussed. First, as valid for any experimental investigation, our study on animals could not provide direct clues for the situation in patients, so that the results of our study in combination with the findings obtained in previous studies may only serve as hints for the direction future research may take. Second, we observed in our study that the intravitreal administration of hESC-HBs was associated with a temporary restoration of the blood-retina barrier function at 2 days after the intravitreal injection of the hESC-HBs, while measurements taken at 4 days and 10 days after the intravitreal cell application were no longer statistically significant. Either the effect of the intravitreal application of the hESC-HBs was short-lived or the number of animals included into the study was not sufficient to have a statistical significance of results when examined 4 and 10 days after the injection. Future studies may address whether the effect of the intraocular hESC-HBs injection was fading rapidly (perhaps necessitating repeated injections). Third, we did not apply any suppression of the immune system in the animals included into the study. As rats as compared to mice have physiologically a stronger immune response to external stimuli, there may be the possibility that the injected human cells were faster attacked in the rats than in mice. Fourth, as already pointed out, the follow-up in our study was short. Fifth, although the importance of functional improvement by far exceeds the importance of morphological improvement, we were, due to the study design, not able to assess the retinal function in our study. Sixth, the model of ischaemia-reperfusion and the OIR model as used in our study represented extremes of clinical situations which usually show a markedly lower degree of ischaemia. It has therefore remained elusive, how far the results of our experimental pilot study could eventually be transferred onto clinical situations, as in many ocular conditions, the development of large ischaemic retinal areas usually does not play the key role. In the case of an acute central retinal artery occlusion or an ischaemic central retinal vein occlusion, however, perhaps similar situations may develop clinically as experimentally induced in our investigation. In particular for these clinical situations, the findings obtained in our study may perhaps be applicable. Seventh, staining for other components of the vessel walls was not performed, so that information on pericytes was not obtained. Eighth, finally it has remained unclear whether functional vessels in the study group were formed due to a direct action and proliferation of the injected HBs or whether the vessel formation resulted from cytokines and growth factors produced by the HBs.
In summary, by integrating into damaged retinal vessels and differentiating into ECs, intravitreally administered hESC-HBs, in contrast to ECs, may have partially repaired a retinal vascular injury caused by OIR model and DR.
